Drugs / P218
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03707041 | Nov 2018 → May 2019 | malaria | Medicines for Malaria Venture | Completed | No outcome recorded |
| Phase 1 | NCT02885506 | Aug 2016 → Dec 2017 | malaria | Medicines for Malaria Venture | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P218 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03707041 ↗ |
| Route | Oral | “single escalating oral doses of P218” NCT02885506 ↗ |